610 results on '"Giles, Jon T."'
Search Results
2. Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years
3. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance
4. Identification of novel biomarkers for the prediction of subclinical coronary artery atherosclerosis in patients with rheumatoid arthritis: an exploratory analysis
5. Left ventricular remodeling in rheumatoid arthritis patients without clinical heart failure
6. Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease
7. Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients
8. Associations of galectin-3 levels with measures of vascular disease in patients with rheumatoid arthritis
9. Adiposity and Interstitial Lung Abnormalities in Community-Dwelling Adults The MESA Cohort Study
10. Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults The Multi-Ethnic Study of Atherosclerosis (MESA)
11. Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study.
12. Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis
13. The monocyte cell surface is a unique site of autoantigen generation in rheumatoid arthritis
14. Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study
15. Improvement in joint inflammation is accompanied by reduction in arterial inflammation: Tocilizumab in rheumatoid arthritis
16. Prospective changes in diastolic function in patients with rheumatoid arthritis
17. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
18. Adipocytokines and Associations With Abnormal Body Composition in Rheumatoid Arthritis
19. Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
20. Plasma adiponectin levels are associated with circulating inflammatory cytokines in autoantibody positive first-degree relatives of rheumatoid arthritis patients.
21. Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis
22. Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial
23. Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
24. Association of Anti–Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis
25. Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis
26. 3 Things You Should Know About Treating Early Rheumatoid Arthritis
27. Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
28. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets
29. Insulin Resistance in Rheumatoid Arthritis: Disease‐Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis
30. Amygdalar activity predicts future incident diabetes independently of adiposity
31. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
32. Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis
33. Moving fast but going slow: coordination challenges for trials of COVID-19 post-exposure prophylaxis
34. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
35. Cystatin C- Versus Creatinine-Based Assessment of Renal Function and Prediction of Early Outcomes Among Patients With a Left Ventricular Assist Device
36. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
37. Additional file 1 of Left ventricular remodeling in rheumatoid arthritis patients without clinical heart failure
38. Small Molecules Targeted For the Treatment of Rheumatoid Arthritis
39. Myocardial Microvascular Dysfunction in Rheumatoid Arthritis: Quantitation by 13N-Ammonia Positron Emission Tomography/Computed Tomography
40. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis
41. Adipocytokines and Associations With Abnormal Body Composition in Rheumatoid Arthritis
42. Impact of Sex and Gender on Autoimmune Lung Disease: Opportunities for Future Research: NHLBI Working Group Report
43. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance
44. Articular18Fluorodeoxyglucose Uptake Is Associated With Clinically Assessed Swollen Joint Count in Patients With Rheumatoid Arthritis
45. Analysis of lumbar spine stenosis specimens for identification of amyloid
46. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
47. Editorial: Tumor Necrosis Factor Antagonists: Killing Two Birds With One Biologic Stone
48. Arterial Inflammation Detected With 18F‐Fluorodeoxyglucose–Positron Emission Tomography in Rheumatoid Arthritis
49. Coronary Artery Inflammation in Rheumatoid Arthritis Using Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography
50. Abstract 15624: Resting Amygdalar Activity Independently Predicts Diabetes Risk Across Levels of Adiposity: A Mechanism Linking Chronic Stress and Metabolic Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.